- Home
- KRYS vs HHH Comparison
KRYS vs HHH Comparison
Compare KRYS & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- HHH
- Stock Information
- Founded
- KRYS 2015
- HHH 2010
- Country
- KRYS United States
- HHH United States
- Employees
- KRYS N/A
- HHH N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- HHH Real Estate Investment Trusts
- Sector
- KRYS Health Care
- HHH Real Estate
- Exchange
- KRYS Nasdaq
- HHH Nasdaq
- Market Cap
- KRYS 4.3B
- HHH 3.3B
- IPO Year
- KRYS 2017
- HHH N/A
- Fundamental
- Price
- KRYS $152.08
- HHH $70.59
- Analyst Decision
- KRYS Strong Buy
- HHH Buy
- Analyst Count
- KRYS 11
- HHH 2
- Target Price
- KRYS $204.27
- HHH $80.50
- AVG Volume (30 Days)
- KRYS 273.6K
- HHH 382.9K
- Earning Date
- KRYS 08-04-2025
- HHH 08-06-2025
- Dividend Yield
- KRYS N/A
- HHH N/A
- EPS Growth
- KRYS 109.01
- HHH N/A
- EPS
- KRYS 4.16
- HHH 5.22
- Revenue
- KRYS $333,448,000.00
- HHH $1,793,533,000.00
- Revenue This Year
- KRYS $40.10
- HHH N/A
- Revenue Next Year
- KRYS $49.73
- HHH $22.53
- P/E Ratio
- KRYS $36.60
- HHH $13.50
- Revenue Growth
- KRYS 247.53
- HHH 106.40
- 52 Week Low
- KRYS $122.80
- HHH $59.83
- 52 Week High
- KRYS $213.52
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- KRYS 58.86
- HHH 56.15
- Support Level
- KRYS $147.35
- HHH $68.79
- Resistance Level
- KRYS $154.99
- HHH $71.22
- Average True Range (ATR)
- KRYS 4.29
- HHH 1.26
- MACD
- KRYS 0.08
- HHH 0.04
- Stochastic Oscillator
- KRYS 66.32
- HHH 71.10
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.